Emergency department-initiated outpatient parenteral antimicrobial therapy in Taiwan: A retrospective cohort study on clinical outcomes and cost analysis
Journal of Microbiology, Immunology and Infection · Published 2025-11-18 · DOI 10.1016/j.jmii.2025.11.001
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.jmii.2025.11.001
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- Significant determinants of plasma procalcitonin concentrations in adult patients hospitalized in intensive care units with monomicrobial Gram-negative bacteremia · Journal of Microbiology, Immunology and Infection · 2025 · Same journal
- Rapid progressive PML-IRIS presenting as multifocal infarcts and uncal herniation in a newly diagnosed person with HIV — case report and literature review · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- Is the HIV-2 pandemic going extinct 40 years after virus discovery? · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- The 2025 guidance on the surveillance and control of Candida infections: Recommendations from the China invasive fungal surveillance net (CHIF-NET) study group · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- Molecular and clinical characterization of human adenovirus type 21 (HAdV-21) associated with respiratory tract infections in hospitalized adults in Hangzhou, China, 2022–2024 · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- Discriminating ST3 and non‐ST3 Staphylococcus lugdunensis using MALDI‐TOF and machine learning analysis · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- Natural killer cells are required for imiquimod-induced psoriasis-like skin inflammation in mice · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- Synergistic activity of mitomycin C in combination with ciprofloxacin against severe Vibrio vulnificus infection · Journal of Microbiology, Immunology and Infection · 2026 · Same journal
- Common human coronavirus-induced cross-reactive salivary antibodies exhibit neutralizing activity and protective potential against SARS-CoV-2 · Journal of Microbiology, Immunology and Infection · 2025 · Same journal
- Breakthrough invasive fusariosis under posaconazole prophylaxis in a neutropenic lymphoma patient · Journal of Microbiology, Immunology and Infection · 2026 · Same journal